Zynerba Pharmaceuticals, Inc.

États‑Unis d’Amérique


Commandez votre montre hebdomadaire
Quantité totale PI 56
Rang # Quantité totale PI 24 779
Note d'activité PI 2,4/5.0    33
Rang # Activité PI 23 350
Symbole boursier
ISIN US98986X1090
Capitalisation 107M  (USD)
Industrie Biotechnology
Secteur Healthcare
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

31 6
8 0
11 0
0
 
Dernier brevet 2025 - Synthetic transdermal cannabidio...
Premier brevet 2005 - Transdermal delivery of cannabidiol
Dernière marque 2023 - ZYGEL
Première marque 2014 - ZYNERBA

Industrie (Classification de Nice)

Derniers inventions, produits et services

2024 Invention Synthetic transdermal cannabidiol for the treatment of focal epilepsy in adults. The present tec...
Invention Prodrugs of tetrahydrocannabinol compositions comprising prodrugs of tetrahydrocannabinol and met...
Invention Treatment of irritability in subjects with autism spectrum disorders with moderate to severe anxi...
2023 Invention Treatment of fragile x syndrome with cannabidiol. The present technology relates to a method of ...
P/S Pharmaceutical preparations for the treatment of human and veterinary diseases and disorders, nam...
Invention Methods of treatment of osteoarthritis with transdermal cannabidiol gel. A pharmaceutical compos...
2022 Invention Treatment of 22q11.2 deletion syndrome with cannabidiol. The present technology relates to metho...
Invention Treatment of fragile x syndrome with cannabidiol. The present technology relates to a method of t...
Invention Treatment of behavioral impairment in developmental and epileptic encephalopathy. The present te...
Invention Treatment of sleep apnea with cbd. Provided are methods of treating sleep disorders in patients ...
Invention Treatment of sleep apnea with cbd. Provided are methods of treating sleep disorders in patients b...
2021 Invention Cannabidiol for the treatment of refractory seizures. Provided are methods of treating refractor...
Invention Cannabidiol for the treatment of refractory seizures. Provided are methods of treating refractory...
Invention Prodrugs of tetrahydrocannabinol, compositions comprising prodrugs of tetrahydrocannabinol and me...
Invention Treatment of autism with cannabidiol. The present technology relates to a method of treating one...
Invention Treatment of autism spectrum disorder with cannabidiol. The present technology relates to a metho...
Invention Treatment of fragile x syndrome and autism spectrum disorder with cannabidiol. The present techn...
2020 Invention Treatment of behavioral impairment in developmental and epileptic encephalopathy. The present tec...
Invention Treatment of syngap1 encephalopathy. The present technology relates to methods of treating SYNGAP...
Invention Treatment of syngap1 encephalopathy. The present technology relates to methods of treating SYNGA...
2019 Invention Treatment of 22q11.2 deletion syndrome with cannabidiol. The present technology relates to method...
Invention Treatment of autism with cannabidiol. The present technology relates to a method of treating one ...
2018 Invention Use of cannabidiol prodrugs in pharmaceutical compositions. Described herein are cannabidiol prod...
Invention Synthetic transdermal cannabidiol for the treatment of focal epilepsy in adults. The present tech...
Invention Synthentic transdermal cannabidiol for the treatment of focal epilepsy in adults. The present te...
Invention Methods of treatment of osteoarthritis with transdermal cannabidiol gel. A pharmaceutical composi...
2014 P/S Pharmaceutical and therapeutic drug development services; pharmaceutical and therapeutic drug res...